Skip to main content

Pedro Alejandro Gil Millán

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Pedro Alejandro Gil Millán

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Individualización de la Monitorización continua de glucosa en la población anciana con diabetes mellitus tipo 2 en función del Estado cognitivo

IP: Monica Sanchez Bartres
Collaborators: Angel Michael Ortiz Zuñiga, Ana Maria Ortiz de Urbina Olive, Judit Amigó Farran, Mercè Abad Martín, Olga Simó Servat, Pedro Alejandro Gil Millán
Funding agency: Sociedad Española de Diabetes
Funding: 20000
Reference: SED/SANCHEZ/2023
Duration: 01/12/2023 - 31/05/2025

Resistencia a la insulina en la diabetes tipo 2: clarificando el mecanismo patogénico de la resistencia a la insulina miocárdica y los efectos de tratamientos con GLP-1 RA y SGLT2i

IP: José Raul Herance Camacho
Collaborators: Sofia Rodriguez Fernandez, Sergi Velasco Vila, Clara Ramírez Serra, Azahara Maria Palomar Muñoz, Cristina Gamez Cenzano, Jana Vidal Otero, Carolina Aparicio Gomez, Alberto Roque Pérez, Queralt Martin Saladich, Resistencia a la insulina en la diabetes tipo 2: clarificando el mecanismo patogénico de la resistencia a la insulina miocárdica, Mercè Abad Martín, Olga Simó Servat, Pedro Alejandro Gil Millán, Maria Nazarena Pizzi, Emily Betancourt Fernández, Enrique Franky Vargas, Eser Ucar, Martha Sahylí Ortega Pijeira
Funding agency: Instituto de Salud Carlos III
Funding: 252500
Reference: PI24/01356
Duration: 01/01/2025 - 31/12/2027

Related news

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.

Related professionals

Alicia Fresno González

Alicia Fresno González

Administration and Management
Cardiovascular Diseases
Read more
Silvia Serres Soler

Silvia Serres Soler

Tècnic/a Grau Superior
Unitat legal
Legal Directorate
Read more
Maria Pallares Masmitja

Maria Pallares Masmitja

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Nuria Gonzalez Llorens

Nuria Gonzalez Llorens

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.